Dr. Reddy’s Laboratories launches eye drops for post-surgery care in United States

The Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA.

Dr. Reddy's, Dr Reddy's labs, Difluprednate Ophthalmic Emulsion, eye drops, eye care, health news, pharma news,
Dr. Reddy's Laboratories (File)

Dr. Reddy’s Laboratories Ltd. on Friday announced that it has launched Difluprednate Ophthalmic Emulsion 0.05%.

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem. This medication belongs to a class of drugs known as corticosteroids.

According to Dr. Reddy’s Labs, it is a therapeutic generic equivalent to Durezol (Difluprednate Ophthalmic Emulsion 0.05%) in the U.S. market, following the approval by the U.S. Food and Drug Administration (USFDA).

The Durezol brand and generic had U.S. sales of approximately $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA.

Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05% is available in 5 ml bottles in case packs of 24.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

This article was first uploaded on January twenty-seven, twenty twenty-three, at eighteen minutes past one in the afternoon.
Market Data
Market Data